BioNexus Gene Lab Corp. (BGLC) NASDAQ

5.49

+0.02(+0.37%)

Updated at October 01 10:42AM

Currency In USD

Valuation

Market Cap4.99M
Enterprise Value822,304
P/E Ratio-3.36
PEG Ratio0.09
Price/Sales Ratio1.03
Price/Book Ratio1.31
Enterprise/Revenue0.97
Enterprise/EBITDA-3.24

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.31
Operating Margin-0.31

Management Effectiveness

Return On Assets-0.31
Return On Equity-0.36

Income Statement

Revenue9.51M
Revenue/Share5.32
Gross Profit1.29M
EBITDA-1.42M
Net Income-1.6M
Diluted EPS-0.9

Balance Sheet

Total Cash3.06M
Total Cash/Share1.7
Total Debt197,156
Total Debt/Equity0.03
Current Ratio3.63
Book Value Per Share4.19

Price History

52-Week Change26.79
52-Week High15.6
52-Week Low2.01
Moving Average 50 Days5.47
Moving Average 200 Days3.91

Statistics

Average Volume1.24M
Shares Outstanding1.8M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split Factor1:10
Last Split DateApril 07, 2025